As the COVID-19 pandemic fades, we may debate whether public health responses could have been better. But first we need to understand what public health errors are — and are not.
Academic rigor, journalistic flair
Articles on COVID-19 vaccines
Displaying 1 - 20 of 570 articles
Vaccine policies fall on a spectrum, from mandates to recommendations. Deciding what to use and when is not so much a science but a balancing act between personal autonomy and public good.
Newly approved and updated vaccines are the best tools available to combat COVID-19, the flu and RSV, as infections and hospitalizations tick upward and cold and flu season gets underway.
To build trust with an audience, scientists must demonstrate that they are competent experts. But they must also come across as warm, caring and human.
Only time and data will tell whether the CDC-recommended reformulated shots can stand their ground against the ever-changing SARS-CoV-2 variants.
Specific beliefs may have more to do with people’s vaccine views than their religious affiliation – but it depends on which vaccine you’re talking about.
COVID-19 vaccination has been shown to be safe in pregnancy, and protects both the mother and infant from severe disease. It’s now also clear that infants’ antibody protection continues after birth.
New analysis answers questions about the ongoing effectiveness of COVID vaccines: How well they protect against infection, hospitalization and death months after initial doses or after a booster shot.
The emergency status allowed the federal government to cut through a mountain of red tape, with the goal of responding to the pandemic more efficiently.
From cancer immunotherapy and antibiotics to GMO crops and pandemic surveillance, gain of function is a cornerstone of basic research.
COVID-19 is the third-leading cause of death in Canada, but it’s older people who are dying. That we accept this and carry on as if the pandemic is over reveals our ageism: We don’t value older people.
Vaccination is often combined with an injection. It can also take the form of a nasal spray: an approach that is still rare, but which could be effective against Covid. Here’s why.
President Joe Biden’s intention to end the national COVID-19 emergency will have long-lasting ripple effects on federal programs such as Medicare, Medicaid and the Children’s Health Insurance Program.
Many questions remain about next steps for US vaccine policy. But the FDA advisory panel’s hearty endorsement of a single-composition COVID-19 vaccine represents a pivotal step.
The XBB.1.5 subvariant — nicknamed ‘Kraken’ — is arguably the most genetically rich and most transmissible SARS-CoV-2 Omicron subvariant yet.
An effective nasal vaccine could stop the virus that causes COVID-19 right at its point of entry. But devising one that works has been a challenge for researchers.
Systemic social issues affect vaccine access and acceptability. Yet, the term ‘vaccine hesitancy’ overlooks this, reducing the multiple factors that affect vaccine uptake to individual-level choices.
Nurses who identify as Democrats have a significantly higher likelihood of having their children vaccinated against COVID-19 than those who identify as Republicans.
Respiratory viruses are hitting young children and infants particularly hard this fall and winter season, and experts don’t yet know exactly why.
Flu and COVID-19 are expected to make headway during the current respiratory virus season. The best way to stay healthy is vaccination in conjunction with personal protective measures.
Top contributors
-
Associate professor, UNSW Sydney
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
-
Associate professor, The University of Western Australia
-
Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Associate Professor, Epidemiology, Deakin University
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Assistant Professor of Political Science, Oklahoma State University
-
Instructor of Human Immunology, Emory University
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Chair in Epidemiology, Deakin University
